from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0811c/-

LFCtreatmentdescriptionclass of inhibitor

-0.002

Amikacinug/mL Amikacintranslation

0.140

Cap5-10ug/mL Capreomycintranslation

-0.452

Rox10-50 ug/mL Roxithromycintranslation

-0.544

SM2-5 ug/mL Streptomycintranslation

-0.443

Tet5-10 ug/mL Tetracyclinetranslation

0.448

Rif0.2-5ug/mL Rifampicintranscription

-0.214

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.623

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.463

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.123

CPZ10-50 ug/mL Chlorpromazinerespiration

0.709

Clofazimine10-13 ug/mL Clofaziminerespiration

0.755

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.450

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.387

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.165

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.672

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.573

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.363

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.496

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.385

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.799

KCN5-20 ug/mL Potassium cyaniderespiration

1.733

NaN30.2-2 mM Sodium aziderespiration

-0.426

Nigericin50 uM Nigericinrespiration

0.853

TRC10-150 ug/mL Triclosanrespiration

1.667

TRZ10-25 ug/mL Thioridazinerespiration

-0.435

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.075

menadione6-10 ug/mL Menadionerespiration

0.662

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.449

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.447

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.423

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.564

NRP_1Non-replicating persistence stage 1dosRassociated

-0.664

Amp0.2mg/mL AmpicillincellWall

0.267

Cephalexin20-100 ug/mL CephalexincellWall

0.269

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.755

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.210

EMB10-20 ug/mL EthambutolcellWall

0.313

Eta12-40 ug/mL EthionamidecellWall

0.260

INH0.2-0.4 ug/mL IsoniazidcellWall

0.066

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.411

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.318

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.505

BZA0.12 mg/mL BenzamidearomaticAmides

-0.621

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.715

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.270

H2O24 mM hydrogen peroxideDNAdamaging

-0.027

Levo10 ug/mL LevofloxacinDNAdamaging

-1.024

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.049

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.718

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.243

UVUV-irradiationDNAdamaging

1.248

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.057

Antimycin12.5-50 ug/mL Antimycin A?

-0.854

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.134

PA_110-50 ug/mL Antitubercular compound PA-1?

0.499

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.389

PA8240.2-2 ug/mL PA-824?

1.463

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.604

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.383

Verapamil50 uM Verapamil?

-0.596

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.876

methoxatin10-20 ug/mL Methoxatin?